Qventus

Qventus

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.qventus.com

Last Round

Series D

Jan 13, 2025

Est. Valuation

$400M

Total Funding Raised

$201.72M

Company Overview

Qventus is a healthcare technology company that provides an AI-powered software platform designed to automate and optimize hospital operations. By leveraging artificial intelligence, machine learning, and behavioral science, the platform helps hospitals and health systems improve efficiency, reduce administrative workloads for staff, and enhance patient flow. The company's solutions address operational challenges in various care settings, including emergency departments, surgical services, and inpatient areas, with the goal of reducing costs, unlocking capacity, and growing revenue for its healthcare partners. Qventus offers specific solutions like its Surgical Growth and Inpatient Capacity products and has launched AI Operational Assistants to act as 'AI teammates' for frontline staff.

Sector

Healthcare & Life Sciences

Verticals

Workflow Automation, Vertical SaaS, Medical AI, Healthcare Analytics, Revenue Cycle

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

hospital automationpatient flow automationhospital command centerEHR integrationOR utilizationinpatient capacity managementhospital AIoperating room optimizationautomated discharge planninghealth system automationperioperative coordinationpredictive analyticsAI solution factoryelectronic health recordsEHRbehavioral science

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qventus Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qventus Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series DJan 13, 2025
Series C ExtensionAug 10, 2022
Series CFeb 28, 2022
Series BMay 14, 2018
Series ANov 16, 2016
Seed
Jan 1, 2015

Key People

Founding team and executive leadership

Mudit Garg

Founder, CEO

Founding Team

Jeff Mounzer

Chief Product Officer

Executive Team

Qventus Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2026

    Joined Oracle's partner program to automate operations in care settings.

  • Feb 26, 2026

    AI-powered platform embedded in EHR to identify missed diagnoses and automate documentation.

Qventus Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qventus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qventus's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range236
Year Founded2012
Last FundingJan 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.